The TRaditional versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) trial: design and baseline characteristics of participants

Overview of attention for article published in Contemporary Clinical Trials, October 2025

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (74th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 6 X users

bluesky: 2 Bluesky users

Readers on

mendeley: 9 Mendeley

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 43,036 followers.

RT @FixelInstitute: What’s the best way to treat MS early on? Dr. Torge Rempe is contributing to the ongoing TREAT-MS study, a nationwide e…

What’s the best way to treat MS early on? Dr. Torge Rempe is contributing to the ongoing TREAT-MS study, a nationwide effort to better understand how treatment choices affect long-term outcomes. Read more here! https://t.co/3y7Bb8jYbg https://t.co/DxmJtR0…

RT @IJMSCtweets: "Herein, we describe the TRaditional versus Early Aggressive Therapy for MS (TREAT-MS) trial design and provide the baseli…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.